| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |